Dirix, Luc <br/><br/>
Effect of Itraconazole and Rifampin on the Pharmacokinetics of Olaparib in Patients With Advanced Solid Tumors: Results of Two Phase I Open-label Studies.  [electronic resource] 

 -  Clinical therapeutics  Oct 2016 
 - 2286-2299 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1879-114X 
<br/><br/><label>Standard No.: </label>10.1016/j.clinthera.2016.08.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--administration & dosage<br/>Area Under Curve<br/>Cytochrome P-450 CYP3A Inhibitors--pharmacology<br/>Cytochrome P-450 Enzyme System--drug effects<br/>Female<br/>Humans<br/>Itraconazole--administration & dosage<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Phthalazines--administration & dosage<br/>Piperazines--administration & dosage<br/>Rifampin--administration & dosage